Cost-effectiveness of PET and PET/Computed Tomography: A Systematic Review

Oke Gerke; Ronnie Hermansson; Søren Hess; Søren Schifter; Werner Vach; Poul Flemming Høilund-Carlsen

doi:10.1016/j.cpet.2014.09.008

Cost-effectiveness of PET and PET/Computed Tomography: A Systematic Review

Oke Gerke, Ronnie Hermansson, Søren Hess, Søren Schifter, Werner Vach, Poul Flemming Høilund-Carlsen

Syddansk Universitet

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

Abstract

The development of clinical diagnostic procedures comprises early-phase and late-phase studies to elucidate diagnostic accuracy and patient outcome. Economic assessments of new diagnostic procedures compared with established work-ups indicate additional cost for 1 additional unit of effectiveness measure by means of incremental cost-effectiveness ratios when considering the replacement of the standard regimen by a new diagnostic procedure. This article discusses economic assessments of PET and PET/computed tomography reported until mid-July 2014. Forty-seven studies on cancer and noncancer indications were identified but, because of the widely varying scope of the analyses, a substantial amount of work remains to be done.

Originalsprog	Engelsk
Tidsskrift	P E T Clinics
Vol/bind	10
Udgave nummer	1
Sider (fra-til)	105-124
ISSN	1556-8598
DOI	https://doi.org/10.1016/j.cpet.2014.09.008
Status	Udgivet - jan. 2015

Dokumenter og links

10.1016/j.cpet.2014.09.008

Citationsformater

@article{70eec6de04b14c19bba1b28a75147160,

title = "Cost-effectiveness of PET and PET/Computed Tomography: A Systematic Review",

abstract = "The development of clinical diagnostic procedures comprises early-phase and late-phase studies to elucidate diagnostic accuracy and patient outcome. Economic assessments of new diagnostic procedures compared with established work-ups indicate additional cost for 1 additional unit of effectiveness measure by means of incremental cost-effectiveness ratios when considering the replacement of the standard regimen by a new diagnostic procedure. This article discusses economic assessments of PET and PET/computed tomography reported until mid-July 2014. Forty-seven studies on cancer and noncancer indications were identified but, because of the widely varying scope of the analyses, a substantial amount of work remains to be done.",

keywords = "Computed tomography, Cost-benefit analysis, Cost-effectiveness, Economics, PET, Fluorodeoxyglucose F18/economics, Humans, Multimodal Imaging/economics, Positron-Emission Tomography/economics, Internationality, Neoplasms/economics, Radiopharmaceuticals/economics, Health Care Costs/statistics & numerical data, Tomography, X-Ray Computed/economics, Cost-Benefit Analysis/economics",

author = "Oke Gerke and Ronnie Hermansson and S{\o}ren Hess and S{\o}ren Schifter and Werner Vach and H{\o}ilund-Carlsen, {Poul Flemming}",

year = "2015",

month = jan,

doi = "10.1016/j.cpet.2014.09.008",

language = "English",

volume = "10",

pages = "105--124",

journal = "P E T Clinics",

issn = "1556-8598",

publisher = "W.B.Saunders Co.",

number = "1",

}

TY - JOUR

T1 - Cost-effectiveness of PET and PET/Computed Tomography

T2 - A Systematic Review

AU - Gerke, Oke

AU - Hermansson, Ronnie

AU - Hess, Søren

AU - Schifter, Søren

AU - Vach, Werner

AU - Høilund-Carlsen, Poul Flemming

PY - 2015/1

Y1 - 2015/1

N2 - The development of clinical diagnostic procedures comprises early-phase and late-phase studies to elucidate diagnostic accuracy and patient outcome. Economic assessments of new diagnostic procedures compared with established work-ups indicate additional cost for 1 additional unit of effectiveness measure by means of incremental cost-effectiveness ratios when considering the replacement of the standard regimen by a new diagnostic procedure. This article discusses economic assessments of PET and PET/computed tomography reported until mid-July 2014. Forty-seven studies on cancer and noncancer indications were identified but, because of the widely varying scope of the analyses, a substantial amount of work remains to be done.

AB - The development of clinical diagnostic procedures comprises early-phase and late-phase studies to elucidate diagnostic accuracy and patient outcome. Economic assessments of new diagnostic procedures compared with established work-ups indicate additional cost for 1 additional unit of effectiveness measure by means of incremental cost-effectiveness ratios when considering the replacement of the standard regimen by a new diagnostic procedure. This article discusses economic assessments of PET and PET/computed tomography reported until mid-July 2014. Forty-seven studies on cancer and noncancer indications were identified but, because of the widely varying scope of the analyses, a substantial amount of work remains to be done.

KW - Computed tomography

KW - Cost-benefit analysis

KW - Cost-effectiveness

KW - Economics

KW - PET

KW - Fluorodeoxyglucose F18/economics

KW - Humans

KW - Multimodal Imaging/economics

KW - Positron-Emission Tomography/economics

KW - Internationality

KW - Neoplasms/economics

KW - Radiopharmaceuticals/economics

KW - Health Care Costs/statistics & numerical data

KW - Tomography, X-Ray Computed/economics

KW - Cost-Benefit Analysis/economics

U2 - 10.1016/j.cpet.2014.09.008

DO - 10.1016/j.cpet.2014.09.008

M3 - Journal article

C2 - 25455883

SN - 1556-8598

VL - 10

SP - 105

EP - 124

JO - P E T Clinics

JF - P E T Clinics

IS - 1

ER -

Cost-effectiveness of PET and PET/Computed Tomography: A Systematic Review

Abstract

Dokumenter og links

Fingeraftryk

Citationsformater